Mentor moms: can peer support cut alcohol use and HIV risk in pregnancy?

NCT ID NCT06962592

Recruiting now Disease control Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a program called Mentor Moms+ for pregnant women in South Africa who drink alcohol. Trained mentor mothers—women who have successfully reduced alcohol use while on HIV medication—provide one-on-one counseling sessions. The goal is to see if this approach helps women reduce alcohol use and stick to HIV prevention or treatment medications. One hundred pregnant women will take part and be followed for six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: peer-led motivational interviewing sessions by mentor mothers
What this could lead to: If successful, this could provide a community-based model to reduce alcohol use and improve HIV medication adherence among pregnant women.
What could go wrong: This is a small pilot study (100 participants) with no control for long-term effects. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL CONSUMPTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alcohol Drinking Breast Feeding HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL CONSUMPTION HIV

Contacts and locations

Locations

Saldanha Bay Clinics
RECRUITING

Saldanha Bay, Western Cape, South Africa
Saldanha Bay Municipality Clinic
NOT_YET_RECRUITING

Cape Town, Western Cape, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.